2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS

Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1090-1091. doi: 10.1007/s00259-021-05562-2. Epub 2021 Sep 22.
No abstract available

MeSH terms

  • Brain* / metabolism
  • Cell- and Tissue-Based Therapy
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals
  • Receptors, Chimeric Antigen*

Substances

  • Radiopharmaceuticals
  • Receptors, Chimeric Antigen
  • Fluorodeoxyglucose F18